Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

These drugs, called GLP1-RAs (short for glucagon-like peptide-1 receptor agonists), have been found to reduce hospital visits ...

This approval makes Ozempic the first GLP-1 treatment for patients with both conditions. Chronic kidney disease is common in people with diabetes. About one in three adults with diabetes have kidney ...

Bayer's big investment in time and money on the development of finerenone for chronic kidney disease (CKD ... other countries for patients with CKD and type 2 diabetes. Bayer meanwhile is also ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in ...

Body-weight cycling in T1D patients is associated with increased ... health outcomes in individuals with type 1 diabetes. Chronic kidney disease has been linked to yo-yo dieting (also known ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney ...